here a high-throughput UCH-L1 enzymatic assay, the is reversible, competitive, and active site directed. Two application of that assay to screen a library of 42,000 isatin oxime inhibitors increased proliferation of the drug-like compounds, and the optimization of the "hits" H1299 lung tumor cell line but had no effect on a lung from that screen. One class of inhibitors, O-acyl oxime tumor line that does not express UCH-L1. Inhibition derivatives of isatins, demonstrated that UCH-L1 activity of UCH-L1 expression in the H1299 cell line using RNAi opposes proliferation. This class of compounds may had a similar proproliferative effect, suggesting that also be useful for elucidating the etiological role of UCHthe UCH-L1 enzymatic activity is antiproliferative and L1 in PD [9]. that UCH-L1 expression may be a response to tumor growth. The molecular mechanism of this response remains to be determined. Results 
Introduction

Design of UCH-L1 HTS Screen Both UCH-L3 and UCH-L1 catalyze the hydrolysis of Ubiquitin C-terminal hydrolase (UCH-
the reaction was run with excess substrate, multiple (1) molecular weights less than 600 D, (2) log P less than 5, (3) fewer than 5 H bond donors, and (4) fewer than turnovers are observed, so the assay cannot distinguish between inhibitors of ubiquityl enzyme formation and 10 H bond acceptors. From the primary robot-assisted screen, 1% of the compounds showed inhibitory activity inhibitors of ubiquityl enzyme breakdown (subsequent data presented below strongly suggest that our hits are (Ͼ60%) toward UCH-L1. About two-thirds of these compounds were eliminated after repeated manual analysis active site directed and thus probably inhibit the former step). The identification of specific inhibitors for UCH-L1 (secondary screen, see Experimental Procedures). Finally, only those compounds that showed dose-depenacyl enzyme formation was accomplished by screening compound libraries for their ability to inhibit enzymedent inhibition of UCH-L1 and did not interfere with AMC fluorescence were subjected to IC 50 determination mediated cleavage of the AMC fluorophore from ubiquitin-AMC. A minimum reaction time of 30 min was reagainst UCH-L1 and/or UCH-L3 (see Experimental Procedures). quired to screen 3000 compounds. The concentration of UCH-L1 and its substrate Ub-AMC were optimized for the HTS to yield a linear velocity of AMC release over
Compounds from the Libraries Showed Various Degrees of Inhibitory Activity toward UCH-L1 a period of at least half an hour ( Figure 1B) , and thus the decrease in AMC fluorescence emission observed Among the compounds that emerged from the screening process, a set of oxime derivatives of isatin (1-8) demonafter quenching of the reaction correlates to enzyme inhibition. The ZЈ factor, a standard statistical parameter strated micromolar IC 50 values toward UCH-L1 and a consistent preference for UCH-L1 over UCH-L3 (Figure for HTS assays that is reflective of both the assay signal dynamic range and the data variation associated with 2A). Molecules of this class, albeit not these specific acyl oximes, have previously been reported to have the signal measurements, was determined to be 0.61 (n ϭ 51 for both positive and negative controls in three antitelomerase activity [29] , ion channel-activating activity [30] , antagonism of excitatory amino acids [31] , separate 384-well plates), indicative of a robust HTS assay (Ͼ0.5) [27] .
and inhibitory activity for c-Jun N-terminal kinase (JNK) [32] . During the screening process, some inhibitors were The screening library consisted of 42,000 compounds that, in general, had the following characteristics [28] :
found to be selective for UCH-L3 over UCH-L1 (Figure 2B). These compounds included menadione 9 (vitamin the benzo portion of the isatin ring tolerated a variety of substituents (R 1 ). K 3 ), 10, and 11, the latter of which is selective for UCH-L3 over UCH-L1 by over 100-fold.
Continued Analysis of Isatin Oxime Structure-Activity Relationship for UCH-L1 Inhibitory Activity Structure-Activity Relationship Derived from Analysis of Isatin Derivatives
Oxime and O-acyl oxime derivatives of isatins were prepared according to the following method (Supplemental Eight isatin oximes (1-8) from the primary screen passed the rigorous validation assays and were selective for Figure S1 at http://www.chembiol.com/cgi/content/full/ 10/9/837/DC1). First, the isatins were deprotonated with UCH-L1. A more detailed analysis showed that this class of compounds had IC 50 values for UCH-L1 ranging from sodium hydride in DMF and then alkylated with various benzyl or 2-phenethyl bromides to yield N-alkylated isat-6 M to 51 M with as much as 5-fold selectivity for UCH-L1 over UCH-L3 (Figure 2A ). The screening library ins. Next, these compounds were converted to their corresponding oximes by treatment with hydroxylamine hyalso contained a subset of oxime isatins that had no effect on UCH-L1 hydrolase activity ( Figure 2C ). Several drochloride in methanol:THF (1:1) and the presence of NaOAc at room temperature. Finally, O-acylation was general trends can be drawn from these two sets of compounds with respect to their ability to inhibit UCHaccomplished either with an acid chloride or an anhydride in dichloromethane in the presence of pyridine L1. First, increasing the size of the substituent on R 3 resulted in decreased activity (Figures 2A and 2C ). Nei-(and in some cases 4-N, N-dimethylaminopyridine) to give the O-acyl oxime isatin derivatives. The compounds ther long hydrocarbon chains nor bulky phenyl rings yielded good inhibitors. Second, the phenyl substituent prepared for in vitro enzymatic activity evaluation are shown in Tables 1 and 2 . at the R 2 position appeared to require a linker of at least one carbon. All of the compounds that lacked such a
The structure-activity relationship study was conducted in order to increase UCH-L1 inhibitory potency linker were inactive, although the absence of activity may be partially due to the large R 3 substituents. Finally, and selectivity for UCH-L1 over UCH-L3. First, the data values for UCH-L3 inhibition for 21 and 12 were 33 M (Table 2) . A tether length of one or two carbons between the heterocyclic core and R 2 is optimal. A tether length of zero (see primary library screening data, Figure 2C ) and three atoms (e.g., 36 and 41) resulted in diminished activity. Some additional substitution of the tethering chain was permitted (e.g., 13). However, other substituents were detriAcylated oxime isatin derivatives are shown in blue and nonacylated mental (e.g., 38, 42, and 46) to activity. Electron-withoximes are shown in red.
drawing groups in the 3-and 4-positions of R 2 (e.g., 1 and 18) were preferred over the 2-position (e.g., 19), but disubstituted rings having one of the substituents at the 2-position were tolerated (e.g., 30 and 31). Likewise, shown in Table 1 As the potency toward UCH-L1 increased, the specificity was also improved ( Table 2) . The two best cases tested were 30 and 51, which favored UCH-L1 over UCH-L3 by 28-and 24-fold, respectively ( Figure 3B ). Both compounds had submicromolar IC 50 values for UCH-L1 hydrolase activity. The widening gap between the compounds' activities toward UCH-L1 and UCH-L3 resulted from an increase in UCH-L1 inhibitory activity, with little or no change in UCH-L3 inhibitory activity.
Several other changes to the O-acyl oximes were made to further explore the structure-activity relationship ( Figure 3C ) for UCH-L1 inhibition. For example, isatin derivatives 68 and 69 were not capable of inhibiting UCH-L1 enzymatic activity at the concentration tested (100 M). Likewise, carbamate 64 and the acetyl hydrazones 65 and 66 were prepared. In all cases the UCH-L1 inhibitory activity was diminished (IC 50 Ͼ 40 M). O-alkyl oxime 67 also had lower UCH-L1 inhibitory activity, further supporting the importance of the O-acyl oxime group for activity. buffer and are not chemically altered by UCH-L1. 
O-Acyl Oxime Compounds Are Reversible Competitive Inhibitors of UCH-L1
K i ϭ IC 50 1 ϩ [Ub Ϫ AMC] K M ,(1)
